How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure

doi:10.3748/wjg.v17.i30.3479

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4688)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

514

HTML

3703

Figures (1-5)

236

Tables (1-4)

235

Sum=4688

Aug 14, 2011 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Aug 14, 2011; 17(30): 3479-3486
Published online Aug 14, 2011. doi: 10.3748/wjg.v17.i30.3479

Full Size Figure Download Figure

Figure 3 Annual cost of albumin use at the S Orsola-Malpighi University Hospital, Bologna, Italy, expressed as a percentage of the total pharmaceutical expenditure. The black arrow indicates when the practical guidelines for in-hospital albumin prescription were implemented in July 2003.

Citation: Mirici-Cappa F, Caraceni P, Domenicali M, Gelonesi E, Benazzi B, Zaccherini G, Trevisani F, Puggioli C, Bernardi M. How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. World J Gastroenterol 2011; 17(30): 3479-3486
URL: https://www.wjgnet.com/1007-9327/full/v17/i30/3479.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i30.3479